BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 34816804)

  • 1. Primary epithelioid inflammatory myofibroblastic sarcoma of the brain with EML4::ALK fusion mimicking intra-axial glioma: a case report and brief literature review.
    Kim EE; Park CK; Kang KM; Kwak Y; Park SH; Won JK
    J Pathol Transl Med; 2024 May; 58(3):141-145. PubMed ID: 38766740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelioid sarcoma mimicking angiosarcoma: the value of immunohistochemistry in the differential diagnosis.
    von Hochstetter AR; Meyer VE; Grant JW; Honegger HP; Schreiber A
    Virchows Arch A Pathol Anat Histopathol; 1991; 418(3):271-8. PubMed ID: 1900974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review.
    Dou W; Guan Y; Liu T; Zheng H; Feng S; Wu Y; Wang X; Liu Z
    Front Oncol; 2023; 13():1212529. PubMed ID: 37841422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Epithelioid inflammatory myofibroblastic sarcoma treated with an ALK TKI ensartinib.
    Li M; Xing R; Huang J; Shi C; Wei C; Wang H
    Front Oncol; 2023; 13():1084456. PubMed ID: 37035183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory Myofibroblastic Tumour: State of the Art.
    Gros L; Dei Tos AP; Jones RL; Digklia A
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelioid inflammatory myofibroblastic sarcoma with VCL-ALK fusion of central nervous system: case report and brief review of the literature.
    Chopra S; Maloney N; Wang WL
    Brain Tumor Pathol; 2022 Jan; 39(1):35-42. PubMed ID: 34743247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
    Parker BM; Parker JV; Lymperopoulos A; Konda V
    J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 and ALK combination therapy has high therapeutic potency in RANBP2-ALK-rearranged epithelioid inflammatory myofibroblastic sarcoma.
    Fordham AM; Xie J; Gifford AJ; Wadham C; Morgan LT; Mould EVA; Fadia M; Zhai L; Massudi H; Ali ZS; Marshall GM; Lukeis RE; Fletcher JI; MacKenzie KL; Trahair TN
    Br J Cancer; 2020 Sep; 123(7):1101-1113. PubMed ID: 32684628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
    Yu L; Liu J; Lao IW; Luo Z; Wang J
    Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
    Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
    Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary Cutaneous Epithelioid Inflammatory Myofibroblastic Sarcoma Harboring RANBP2-ALK Fusion: Report of an Exceptional Case.
    Gadeyne L; Creytens D; Dekeyser S; Van der Meulen J; Haspeslagh M
    Am J Dermatopathol; 2022 Apr; 44(4):302-305. PubMed ID: 34816804
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.